124 related articles for article (PubMed ID: 15998876)
1. Clinical trials point to complexities of chemoprevention for cancer.
Hampton T
JAMA; 2005 Jul; 294(1):29-31. PubMed ID: 15998876
[No Abstract] [Full Text] [Related]
2. Clinical trials referral resource. Breast cancer and prostate cancer.
Brawley OW; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
[No Abstract] [Full Text] [Related]
3. [Chemoprevention of breast cancer. Clinical trials in pharmacological prevention].
Ricart JJ
Medicina (B Aires); 2004; 64(1):66-72. PubMed ID: 15034961
[TBL] [Abstract][Full Text] [Related]
4. [Breast cancer chemoprevention (tamoxifen, raloxifene, and others)].
Funahashi H
Nihon Rinsho; 2000 Apr; 58 Suppl():587-91. PubMed ID: 11026055
[No Abstract] [Full Text] [Related]
5. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
Dunn BK; Ford LG
Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of breast cancer.
O'Regan RM
Lancet; 2006 Apr; 367(9520):1382-3. PubMed ID: 16650636
[No Abstract] [Full Text] [Related]
7. Despite positive studies, popularity of chemoprevention drugs increasing slowly.
Zielinski SL
J Natl Cancer Inst; 2004 Oct; 96(19):1410-2. PubMed ID: 15467023
[No Abstract] [Full Text] [Related]
8. Chemoprevention of cancer.
Szarka CE; Grana G; Engstrom PF
Curr Probl Cancer; 1994; 18(1):6-79. PubMed ID: 8005001
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
Rollins G
Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
[No Abstract] [Full Text] [Related]
10. [Chemoprevention of prostate cancer. Current status].
Schmitz-Dräger BJ; Lümmen G; Schäfer RM
Urologe A; 2007 Jun; 46(6):611-5. PubMed ID: 17483928
[TBL] [Abstract][Full Text] [Related]
11. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
Runowicz CD
Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
[No Abstract] [Full Text] [Related]
12. [Chemoprevention of breast cancer: a hope justified?].
Buser K; Delaloye JF
Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
[TBL] [Abstract][Full Text] [Related]
13. Future directions in cancer prevention.
Umar A; Dunn BK; Greenwald P
Nat Rev Cancer; 2012 Dec; 12(12):835-48. PubMed ID: 23151603
[TBL] [Abstract][Full Text] [Related]
14. Bone builder vs. breast cancer.
Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
[No Abstract] [Full Text] [Related]
15. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen infrequently used by women at risk for breast cancer.
Dreyfuss JH
CA Cancer J Clin; 2010; 60(4):204-6. PubMed ID: 20530798
[No Abstract] [Full Text] [Related]
17. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
18. The Breast Cancer Continuum: insights from the tamoxifen trials impact future drug development strategies.
Lewis JP
Ann N Y Acad Sci; 2001 Dec; 949():327-32. PubMed ID: 11795371
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention clinical trials: it is time to turn success into progress.
Brown PH
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
[No Abstract] [Full Text] [Related]
20. Chemoprevention of prostate cancer.
Thompson IM; Coltman CA; Brawley OW; Ryan A
Semin Urol; 1995 May; 13(2):122-9. PubMed ID: 7638469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
